1. Introduction to Inflammation and Cancer 2. Chronic Inflammation and Cancer: Epidemiological Evidence 3. The Role of Oxidative Stress in Inflammation-Mediated Cancer Progression 4. Inflammation and Tumor Progression: Signaling Cross-Talk and Therapeutic Resistance 5. Pro-and anti-tumorigenic inflammatory signalling in pancreatic cancer: Mechanistic insights and therapeutic implications 6. Inflammation and Beyond: Complex Roles for TGF-β in the Tumor Microenvironment 7. Cytokines and Chemokines in Tumorigenesis and Their Pro-tumorigenic and Anti-tumorigenic Roles in Cancer Development 8.
Role of Proinflammatory Chemokines and cytokines in Tumor growth and metastasis 9. The role of Cancer-Associated Fibroblasts in Inflammation of Cancer 10. Role of Macrophages in Regulating Tumour Angiogenesis: Implications for Cancer Therapy 11. Cancer stem cell signaling and inflammation 12. Tumour Microenvironment and Inflammation 13. Tumour Infiltrating Lymphocytes as Possible Therapeutic Targets 14. Mechanisms of Immune Exhaustion in Cancer: Key Players and Critical Pathways 15. Modulation of Tumor Immunogenicity in cancer prevention and therapy 16.
Immune Forces Impacting DNA-Based Cancer Immunotherapeutic Strategy 17. lncRNAs as potential modulators for outcomes of immunotherapy in bladder cancer, a comprehensive review 18. Epigenetic Signaling: Regulation of Inflammation in Cancer 19. Gut microbiome and epigenetic changes in developing inflammation and cancer 20. Interplay of the human microbiome, inflammation and colorectal cancer: Emerging insights and therapeutic prospects 21. Metagenomic and Meta-transcriptomic landscapes in cancer 22. The Inflammatory Landscape of Gynecological Cancers: Pathophysiology, Risk, and Therapeutic Potential 23. The Dual Role of Inflammation in Lung Cancer: Regulation of Tumor Growth via MAPK Pathway 24.
Chemopreventive Strategies for Inflammation-Related Carcinogenesis: Current Status and Future Direction 25. Toxicological Responses to Carcinogens: How Inflammation Plays a Dual Role in Cancer Progression 26. Personalized Cancer Treatment: Theranostic and Immunotherapeutic-Based Approaches.